MS Care Study Results
- Of the 171 participants randomized to either MS Care or usual care, 167 (97.7%) completed the study intervention and post-treatment outcome assessments.
- The sample was representative of the population of adults with MS in terms of age, sex, race, ethnicity, relationship status, work status, and disease duration.
- Although participants could enroll due to difficulty with pain, depression, or both, the majority of participants enrolled with moderate or severe pain (72%) or both pain and depression (23%); few individuals enrolled only had depression (5%).
- Participants were offered the choice of in person or telephone care management sessions and opted to do 75% of their sessions by telephone
At the end of the treatment phase, participants in MS Care, compared to those getting usual care, had:
- Significantly better control of their pain and depressive symptoms: 57.6% of those in MS Care had good pain and depression control, as compared to 31.7% in usual care
- Pain severity
- Pain interference
- Depression severity
- Satisfaction with their pain and depression care
- Satisfaction with their healthcare at the MS Center and overall healthcare, despite the fact that both groups entered with existing high levels of satisfaction with care
We also found a very high rate of adherence to the MS Care intervention: 90% received 10-12 sessions of MS Care
- We are analyzing additional outcomes, including use of medications and other treatments, as well as quality of life.
- In March of 2017 we will finish collecting our 6-month follow up assessments to see if improvements were maintained.
- In March and April of 2017 we will collaborate with our stakeholders to interpret the additional study findings and generate other questions to explore in our data.
- In partnership with our stakeholders, we are working on a plan to share the study results with the MS community and implement what we learned into MS Care.
- We are writing the scientific manuscript that will describe the study findings and will submit it to a scientific journal in the Spring of 2017.